177 related articles for article (PubMed ID: 21998751)
21. Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells.
Decker T; Schneller F; Sparwasser T; Tretter T; Lipford GB; Wagner H; Peschel C
Blood; 2000 Feb; 95(3):999-1006. PubMed ID: 10648415
[TBL] [Abstract][Full Text] [Related]
22. Variable induction of PRDM1 and differentiation in chronic lymphocytic leukemia is associated with anergy.
Duckworth A; Glenn M; Slupsky JR; Packham G; Kalakonda N
Blood; 2014 May; 123(21):3277-85. PubMed ID: 24637363
[TBL] [Abstract][Full Text] [Related]
23. TAp63 regulates VLA-4 expression and chronic lymphocytic leukemia cell migration to the bone marrow in a CD74-dependent manner.
Binsky I; Lantner F; Grabovsky V; Harpaz N; Shvidel L; Berrebi A; Goldenberg DM; Leng L; Bucala R; Alon R; Haran M; Shachar I
J Immunol; 2010 May; 184(9):4761-9. PubMed ID: 20357260
[TBL] [Abstract][Full Text] [Related]
24. A novel role for Lef-1, a central transcription mediator of Wnt signaling, in leukemogenesis.
Petropoulos K; Arseni N; Schessl C; Stadler CR; Rawat VP; Deshpande AJ; Heilmeier B; Hiddemann W; Quintanilla-Martinez L; Bohlander SK; Feuring-Buske M; Buske C
J Exp Med; 2008 Mar; 205(3):515-22. PubMed ID: 18316418
[TBL] [Abstract][Full Text] [Related]
25. Heterogeneous functional effects of concomitant B cell receptor and TLR stimulation in chronic lymphocytic leukemia with mutated versus unmutated Ig genes.
Chatzouli M; Ntoufa S; Papakonstantinou N; Chartomatsidou E; Anagnostopoulos A; Kollia P; Ghia P; Muzio M; Stamatopoulos K; Belessi C
J Immunol; 2014 May; 192(10):4518-24. PubMed ID: 24719462
[TBL] [Abstract][Full Text] [Related]
26. B-chronic lymphocytic leukemias can undergo isotype switching in vivo and can be induced to differentiate and switch in vitro.
Malisan F; Fluckiger AC; Ho S; Guret C; Banchereau J; Martinez-Valdez H
Blood; 1996 Jan; 87(2):717-24. PubMed ID: 8555496
[TBL] [Abstract][Full Text] [Related]
27. B-chronic lymphocytic leukemia cells contain both endogenous kappa immunoglobulin mRNA and critical immunoglobulin gene activation transcription factors.
Zaknoen SL; Christian SL; Suen R; Van Ness B; Kay NE
Leukemia; 1992 Jul; 6(7):675-9. PubMed ID: 1625486
[TBL] [Abstract][Full Text] [Related]
28. Dichotomy in NF-kappaB signaling and chemoresistance in immunoglobulin variable heavy-chain-mutated versus unmutated CLL cells upon CD40/TLR9 triggering.
Tromp JM; Tonino SH; Elias JA; Jaspers A; Luijks DM; Kater AP; van Lier RA; van Oers MH; Eldering E
Oncogene; 2010 Sep; 29(36):5071-82. PubMed ID: 20581863
[TBL] [Abstract][Full Text] [Related]
29. Lack of intraclonal diversification in Ig heavy and light chain V region genes expressed by CD5+IgM+ chronic lymphocytic leukemia B cells: a multiple time point analysis.
Schettino EW; Cerutti A; Chiorazzi N; Casali P
J Immunol; 1998 Jan; 160(2):820-30. PubMed ID: 9551917
[TBL] [Abstract][Full Text] [Related]
30. Difference in the relative distribution of CD4+ T-cell subsets in B-CLL with mutated and unmutated immunoglobulin (Ig) VH genes: implication for the course of disease.
Tinhofer I; Weiss L; Gassner F; Rubenzer G; Holler C; Greil R
J Immunother; 2009 Apr; 32(3):302-9. PubMed ID: 19242370
[TBL] [Abstract][Full Text] [Related]
31. Chronic Lymphocytic Leukemia B-Cell Normal Cellular Counterpart: Clues From a Functional Perspective.
Darwiche W; Gubler B; Marolleau JP; Ghamlouch H
Front Immunol; 2018; 9():683. PubMed ID: 29670635
[TBL] [Abstract][Full Text] [Related]
32. High LEF1 expression predicts adverse prognosis in chronic lymphocytic leukemia and may be targeted by ethacrynic acid.
Wu W; Zhu H; Fu Y; Shen W; Miao K; Hong M; Xu W; Fan L; Young KH; Liu P; Li J
Oncotarget; 2016 Apr; 7(16):21631-43. PubMed ID: 26950276
[TBL] [Abstract][Full Text] [Related]
33. Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells.
Petlickovski A; Laurenti L; Li X; Marietti S; Chiusolo P; Sica S; Leone G; Efremov DG
Blood; 2005 Jun; 105(12):4820-7. PubMed ID: 15728130
[TBL] [Abstract][Full Text] [Related]
34. Analysis of expressed and non-expressed IGK locus rearrangements in chronic lymphocytic leukemia.
Belessi C; Stamatopoulos K; Hadzidimitriou A; Hatzi K; Smilevska T; Stavroyianni N; Marantidou F; Paterakis G; Fassas A; Anagnostopoulos A; Laoutaris N
Mol Med; 2005; 11(1-12):52-8. PubMed ID: 16622520
[TBL] [Abstract][Full Text] [Related]
35. Immunostimulatory CpG-oligonucleotides induce functional high affinity IL-2 receptors on B-CLL cells: costimulation with IL-2 results in a highly immunogenic phenotype.
Decker T; Schneller F; Kronschnabl M; Dechow T; Lipford GB; Wagner H; Peschel C
Exp Hematol; 2000 May; 28(5):558-68. PubMed ID: 10812246
[TBL] [Abstract][Full Text] [Related]
36. What do somatic hypermutation and class switch recombination teach us about chronic lymphocytic leukaemia pathogenesis?
Oppezzo P; Dighiero G
Curr Top Microbiol Immunol; 2005; 294():71-89. PubMed ID: 16323428
[TBL] [Abstract][Full Text] [Related]
37. Variation in WNT genes expression in different subtypes of chronic lymphocytic leukemia.
Memarian A; Hojjat-Farsangi M; Asgarian-Omran H; Younesi V; Jeddi-Tehrani M; Sharifian RA; Khoshnoodi J; Razavi SM; Rabbani H; Shokri F
Leuk Lymphoma; 2009 Dec; 50(12):2061-70. PubMed ID: 19863181
[TBL] [Abstract][Full Text] [Related]
38. Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells.
Hashimoto S; Dono M; Wakai M; Allen SL; Lichtman SM; Schulman P; Vinciguerra VP; Ferrarini M; Silver J; Chiorazzi N
J Exp Med; 1995 Apr; 181(4):1507-17. PubMed ID: 7535340
[TBL] [Abstract][Full Text] [Related]
39. Mechanistic Insights into CpG DNA and IL-15 Synergy in Promoting B Cell Chronic Lymphocytic Leukemia Clonal Expansion.
Gupta R; Yan XJ; Barrientos J; Kolitz JE; Allen SL; Rai K; Chiorazzi N; Mongini PKA
J Immunol; 2018 Sep; 201(5):1570-1585. PubMed ID: 30068596
[TBL] [Abstract][Full Text] [Related]
40. Immunoregulatory effects of Lurbinectedin in chronic lymphocytic leukemia.
Risnik D; Colado A; Podaza E; Almejún MB; Elías EE; Bezares RF; Fernández-Grecco H; Seija N; Oppezzo P; Borge M; Gamberale R; Giordano M
Cancer Immunol Immunother; 2020 May; 69(5):813-824. PubMed ID: 32055920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]